INJ consolidates between $4.32 and $4.86 amid dynamic support at MA-20: weekly forecast

Traders Union
All News
Crypto
Injective slips 4.06% this week

Highlights

INJ remains under medium- and long-term selling pressure, trading below major moving averages despite holding short-term support.
Momentum and oscillator signals are mostly negative or neutral, reflecting oversold conditions but limited buyer strength.
Expected price range for the week is $4.32 to $4.86, with a sideways to bearish bias and potential for further declines.

Decentralized finance platform focus as week sees no major news

Injective continues to focus on its core business as a layer-1 blockchain dedicated to decentralized financial applications, including derivatives trading, synthetic assets, and oracles. There have been no major corporate events, regulatory actions, or new product launches reported for the period. The ongoing development of its decentralized finance platform remains a key driver for the project.

Mixed technical signals this week with volatility and bearish indicators

Technical indicators on the weekly chart reflect a mixed outlook. The price holds above the MA-20 but is still capped beneath the MA-50 and MA-200, indicating persistent resistance at higher levels. The weekly MACD issues a Strong Sell, while the ADX shows a slight bullish bias, displaying divergence in the trend signals. The weekly RSI remains bearish, with Stochastic RSI and CCI both neutral, and Bull/Bear Power showing the market as oversold but with some buyer presence. The Awesome Oscillator also hints at a mild bullish tone, while volatility for the week is elevated at 25.74%. Key support lies at $4.32 and resistance at $4.86, based on recent weekly ranges.

Range-bound outlook expected as downside risk outweighs rebound next week

For the next 7 days, INJ is likely to remain range-bound between $4.32 and $4.86 as sideways consolidation continues. With only 25% of key weekly indicators showing a buy signal, the probability of a further decline slightly outweighs a rebound scenario. A break above $4.86 could attract renewed buyers and target the MA-50 near $7.01, while a drop below $4.32 would open the door for a retest of lower weekly supports. Barring a decisive move out of this range, expect subdued direction and moderate price churn.

Anton Kharitonov, expert at Traders Union, notes that Injective has spent the week under continued selling pressure, closing 4.06% lower and still capped under important long-term averages. He observes that despite INJ holding above its weekly MA-20 support, other signals remain mixed — the MACD strongly bearish, while some oscillators suggest a touch of buying activity. No significant project developments or news have changed sentiment, leaving the outlook dependent on technicals. The analyst sees the current range of $4.32 to $4.86 as defining near-term risk, with a slight bias toward further weakness given that only 25% of key weekly indicators signal buying. Unless clear momentum pushes the price above resistance, sideways action or further losses appear more likely. "As long as price stays below $4.86, I remain cautious and prefer to wait for a decisive move before shifting my outlook."

Earlier, analysts noted that Injective’s outlook was shaped by mixed technical signals despite ongoing ecosystem developments and upgrades. The current analysis reinforces this cautious stance, suggesting traders should watch for a sustained breakout above $4.86 or a decisive move below $4.32 as signals of the next directional trend.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.